BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10626797)

  • 1. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
    Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
    Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential subcellular localization of functionally divergent survivin splice variants.
    Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
    Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exonization of Alu-generated splice variants in the survivin gene of human and non-human primates.
    Mola G; Vela E; Fernández-Figueras MT; Isamat M; Muñoz-Mármol AM
    J Mol Biol; 2007 Mar; 366(4):1055-63. PubMed ID: 17204284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
    Meng H; Lu C; Mabuchi H; Tanigawa N
    Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
    Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
    Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.
    Wang HW; Sharp TV; Koumi A; Koentges G; Boshoff C
    EMBO J; 2002 Jun; 21(11):2602-15. PubMed ID: 12032073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.
    Zhu N; Gu L; Findley HW; Li F; Zhou M
    Oncogene; 2004 Sep; 23(45):7545-51. PubMed ID: 15334064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
    Caldas H; Honsey LE; Altura RA
    Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.
    Li F; Altieri DC
    Cancer Res; 1999 Jul; 59(13):3143-51. PubMed ID: 10397257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.
    Hu H; Shikama Y; Matsuoka I; Kimura J
    J Leukoc Biol; 2008 Feb; 83(2):393-400. PubMed ID: 17965335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
    Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N
    Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin.
    Rodríguez JA; Span SW; Ferreira CG; Kruyt FA; Giaccone G
    Exp Cell Res; 2002 Apr; 275(1):44-53. PubMed ID: 11925104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
    Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
    Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
    Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.